홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Carbidopa → Levodopa

HRID 452339
인쇄

반응식

HRID 452339 반응식
C[C@@:2]([NH:15]N)([C:12]([OH:14])=[O:13])[CH2:3][C:4]1[CH:5]=[CH:6][C:7]([OH:11])=[C:8]([OH:10])[CH:9]=1>C1C(CCN)=CC(O)=C(O)C=1>[CH:5]1[C:4]([CH2:3][C@H:2]([NH2:15])[C:12]([OH:14])=[O:13])=[CH:9][C:8]([OH:10])=[C:7]([OH:11])[CH:6]=1
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

3

반응물 1

HCID 34359Carbidopa

생성물 1

HCID 6047Levodopa수율 458.9%

시약·촉매·용매 1

HCID 681Dopamine용매

실험 절차

The in vitro dissolution profile of Sinemet® CR 50-200 tablets, containing 50 mg carbidopa and 200 mg levodopa were obtained under simulated gastric conditions. The dissolution tests were performed in 900 mL of a 0.1 N HCl-pH 1.2 solution, in a USP II apparatus at a temperature of 37° C. The paddle speed was set at 50 rpm. Samples of dissolution media were collected at predetermined intervals and analyzed by HPLC. The dissolution profiles of levodopa and carbidopa obtained from HPLC analysis are shown in FIG. 13.

출처 및 근거

ORD 기록
ord-7eda501e279141dfaef8fb528ff15526
출처 데이터셋
uspto-grants-2013_07
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08491929B2

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트